GPI Group’s transfusion medicine platform, distributed and supported under authorization by NOJ.
e-Delphyn is the flagship of GPI Group’s GPI4Blood portfolio: a fully web-based platform covering the complete blood cycle, from donor recruitment to bedside traceability, deployed in more than 60 countries.
Classified as a medical device with FDA 510(k) clearance, ISBT 128 compliant and HL7-integrated, in the cloud or on your servers. NOJ distributes, implements and supports it under authorization — with impartial guidance versus NOJ Blood Control.
GPI4Blood flagship, deployed in more than 60 countries.
Implementation and guidance in your language and time zone.
We help you choose between e-Delphyn and NOJ Blood Control.